Sverre Holm
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sverre Holm has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Bente Halvorsen
Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
5 shared publications - Pål Aukrust
Faculty of Medicine, University of Oslo, 0318 Oslo, Norway
3 shared publications - Tuva Boerresdatter Dahl
Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway
3 shared publications - Ida Gregersen
Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
2 shared publications - Mona Skjelland
Department of Neurology, Oslo University Hospital, Rikshospitalet, Oslo, Norway
2 shared publications - Thor Ueland
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
2 shared publications
Latest Publications
- Open Access
- 4 February 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (3) , e038316
Alternative Complement Pathway in Carotid Atherosclerosis: Low Plasma Properdin Levels Associate With Long‐Term Cardiovascular Mortality
Background: Complement activation may promote atherosclerosis. Yet, data on the to which extent complement, and more specifically the alternative complement pathway, is activated in patients with carotid atherosclerosis and related to adverse outcome in these patients, are scarce. Methods and Results: We measured, by ELISA, plasma levels of factor D, properdin, C3bBbP (C3 convertase), and factor H in patients with advanced carotid atherosclerosis in a Discovery (n=324) and in a Validation (n=206) cohort in relation to adverse outcome (mean follow‐up 7.8 and 6.6 years, respectively). Our major findings were as follows. Compared with healthy controls, patients with carotid atherosclerosis had increased plasma levels of factor D, properdin, and C3bBbP ( P Discovery (HR 2.31, P =0.019) and the Validation cohort (hazard ratio [HR], 2.81, P =0.014). In contrast to the low circulating levels, high intraplaque properdin levels (assessed by ELISA) correlated with markers of plaque vulnerability and symptomatology. Conclusions: We show a strong and independent association of low plasma properdin levels with cardiovascular mortality in 2 cohorts. Conversely, the plaque properdin levels linked to features of plaque vulnerability, potentially reflecting increased deposition at the site of inflammation or local production of properdin in the atherosclerotic lesion indicating local enhanced alternative complement pathway activation.
- 4 February 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (3) , e038316
Open AccessAlternative Complement Pathway in Carotid Atherosclerosis: Low Plasma Properdin Levels Associate With Long‐Term Cardiovascular Mortality
Background: Complement activation may promote atherosclerosis. Yet, data on the to which extent complement, and more specifically the alternative complement pathway, is activated in patients with carotid atherosclerosis and related to adverse outcome in these patients, are scarce. Methods and Results: We measured, by ELISA, plasma levels of factor D, properdin, C3bBbP (C3 convertase), and factor H in patients with advanced carotid atherosclerosis in a Discovery (n=324) and in a Validation (n=206) cohort in relation to adverse outcome (mean follow‐up 7.8 and 6.6 years, respectively). Our major findings were as follows. Compared with healthy controls, patients with carotid atherosclerosis had increased plasma levels of factor D, properdin, and C3bBbP ( P Discovery (HR 2.31, P =0.019) and the Validation cohort (hazard ratio [HR], 2.81, P =0.014). In contrast to the low circulating levels, high intraplaque properdin levels (assessed by ELISA) correlated with markers of plaque vulnerability and symptomatology. Conclusions: We show a strong and independent association of low plasma properdin levels with cardiovascular mortality in 2 cohorts. Conversely, the plaque properdin levels linked to features of plaque vulnerability, potentially reflecting increased deposition at the site of inflammation or local production of properdin in the atherosclerotic lesion indicating local enhanced alternative complement pathway activation.
- Open Access
- 17 August 2024
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 84 (6) , 425-427
Human papilloma virus vaccine induced thrombocytopenia accompanied by a wide spectrum of reversible inflammatory responses – a case report
- 17 August 2024
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 84 (6) , 425-427
Open AccessHuman papilloma virus vaccine induced thrombocytopenia accompanied by a wide spectrum of reversible inflammatory responses – a case report
- Open Access
MRI Elastography Identifies Regions of Extracellular Matrix Reorganization Associated with Shorter Survival in Glioblastoma Patients
Background: The biomechanical tissue properties of glioblastoma tumors are heterogeneous, but the molecular mechanisms involved and the biological implications are poorly understood. Here, we combine magnetic resonance elastography (MRE) measurement of tissue stiffness with RNA sequencing of tissue biopsies to explore the molecular characteristics of the stiffness signal. Methods: MRE was performed preoperatively in 13 patients with glioblastoma. Navigated biopsies were harvested during surgery and later classified as ‘stiff’ or ‘soft’ according to MRE stiffness measurements (|G*| norm ). Twenty-two biopsies from eight patients were analysed by RNA sequencing. Results: The mean whole-tumor stiffness was lower than in normal-appearing white matter. The surgeon’s biopsy stiffness evaluation did not correlate with the MRE measurements, which suggests that they measure different properties. Gene set enrichment analysis of the differentially expressed genes between ‘stiff’ and ‘soft’ biopsies showed that genes involved in extracellular matrix reorganization and cellular adhesion were overexpressed in ‘stiff’ biopsies. Supervised dimensionality reduction identified a gene expression signal separating ‘stiff ‘and ‘soft’ biopsies. Using the NIH Genomic Data Portal, 265 patients with glioblastoma were divided into patients with (n=63) and without (n=202) this gene expression signal. The median survival time of patients with tumors expressing the gene expression signal associated with ‘stiff’ biopsies was 100 days shorter than that of patients not expressing it (360 versus 460 days, hazard ratio: 1.45, Pin vivo and in situ . For the first time, we present molecular profiling of glioblastoma tissue correlated with in situ stiffness measurements. The transcriptomic profiles of ‘stiff’ and ‘soft’ biopsies showed that extracellular matrix reorganization was strongly associated with the ‘stiff’ biopsies, in particular collagen binding. Genes associated with innate immune processes were also upregulated in ‘stiff’ biopsies, indicating that these are active regions of the tumor. The association between gene expression in ‘stiff’ biopsies and survival is in concordance with previous reports of elevated extracellular matrix stiffness increasing glioblastoma aggression. Key Points: - MR Elastography can provide unique information on intratumoral heterogeneity preoperatively. - MR Elastography identifies tumor regions of active extracellular reorganization - Gene expression signal associated with increased stiffness negatively correlates with survival
Open AccessMRI Elastography Identifies Regions of Extracellular Matrix Reorganization Associated with Shorter Survival in Glioblastoma Patients
Background: The biomechanical tissue properties of glioblastoma tumors are heterogeneous, but the molecular mechanisms involved and the biological implications are poorly understood. Here, we combine magnetic resonance elastography (MRE) measurement of tissue stiffness with RNA sequencing of tissue biopsies to explore the molecular characteristics of the stiffness signal. Methods: MRE was performed preoperatively in 13 patients with glioblastoma. Navigated biopsies were harvested during surgery and later classified as ‘stiff’ or ‘soft’ according to MRE stiffness measurements (|G*| norm ). Twenty-two biopsies from eight patients were analysed by RNA sequencing. Results: The mean whole-tumor stiffness was lower than in normal-appearing white matter. The surgeon’s biopsy stiffness evaluation did not correlate with the MRE measurements, which suggests that they measure different properties. Gene set enrichment analysis of the differentially expressed genes between ‘stiff’ and ‘soft’ biopsies showed that genes involved in extracellular matrix reorganization and cellular adhesion were overexpressed in ‘stiff’ biopsies. Supervised dimensionality reduction identified a gene expression signal separating ‘stiff ‘and ‘soft’ biopsies. Using the NIH Genomic Data Portal, 265 patients with glioblastoma were divided into patients with (n=63) and without (n=202) this gene expression signal. The median survival time of patients with tumors expressing the gene expression signal associated with ‘stiff’ biopsies was 100 days shorter than that of patients not expressing it (360 versus 460 days, hazard ratio: 1.45, Pin vivo and in situ . For the first time, we present molecular profiling of glioblastoma tissue correlated with in situ stiffness measurements. The transcriptomic profiles of ‘stiff’ and ‘soft’ biopsies showed that extracellular matrix reorganization was strongly associated with the ‘stiff’ biopsies, in particular collagen binding. Genes associated with innate immune processes were also upregulated in ‘stiff’ biopsies, indicating that these are active regions of the tumor. The association between gene expression in ‘stiff’ biopsies and survival is in concordance with previous reports of elevated extracellular matrix stiffness increasing glioblastoma aggression. Key Points: - MR Elastography can provide unique information on intratumoral heterogeneity preoperatively. - MR Elastography identifies tumor regions of active extracellular reorganization - Gene expression signal associated with increased stiffness negatively correlates with survival
- Open Access
- 18 January 2022
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 29, 101211
NEIL3-deficient bone marrow displays decreased hematopoietic capacity and reduced telomere length
- 18 January 2022
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 29, 101211
Open AccessNEIL3-deficient bone marrow displays decreased hematopoietic capacity and reduced telomere length
- Open Access
- 22 June 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 28337
Neil3-dependent base excision repair regulates lipid metabolism and prevents atherosclerosis in Apoe-deficient mice
Increasing evidence suggests that oxidative DNA damage accumulates in atherosclerosis. Recently, we showed that a genetic variant in the human DNA repair enzyme NEIL3 was associated with increased risk of myocardial infarction. Here, we explored the role of Neil3/NEIL3 in atherogenesis by both clinical and experimental approaches. Human carotid plaques revealed increased NEIL3 mRNA expression which significantly correlated with mRNA levels of the macrophage marker CD68. Apoe−/−Neil3−/− mice on high-fat diet showed accelerated plaque formation as compared to Apoe−/− mice, reflecting an atherogenic lipid profile, increased hepatic triglyceride levels and attenuated macrophage cholesterol efflux capacity. Apoe−/−Neil3−/− mice showed marked alterations in several pathways affecting hepatic lipid metabolism, but no genotypic alterations in genome integrity or genome-wide accumulation of oxidative DNA damage. These results suggest a novel role for the DNA glycosylase Neil3 in atherogenesis in balancing lipid metabolism and macrophage function, potentially independently of genome-wide canonical base excision repair of oxidative DNA damage.
- 22 June 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 28337
Open AccessNeil3-dependent base excision repair regulates lipid metabolism and prevents atherosclerosis in Apoe-deficient mice
Increasing evidence suggests that oxidative DNA damage accumulates in atherosclerosis. Recently, we showed that a genetic variant in the human DNA repair enzyme NEIL3 was associated with increased risk of myocardial infarction. Here, we explored the role of Neil3/NEIL3 in atherogenesis by both clinical and experimental approaches. Human carotid plaques revealed increased NEIL3 mRNA expression which significantly correlated with mRNA levels of the macrophage marker CD68. Apoe−/−Neil3−/− mice on high-fat diet showed accelerated plaque formation as compared to Apoe−/− mice, reflecting an atherogenic lipid profile, increased hepatic triglyceride levels and attenuated macrophage cholesterol efflux capacity. Apoe−/−Neil3−/− mice showed marked alterations in several pathways affecting hepatic lipid metabolism, but no genotypic alterations in genome integrity or genome-wide accumulation of oxidative DNA damage. These results suggest a novel role for the DNA glycosylase Neil3 in atherogenesis in balancing lipid metabolism and macrophage function, potentially independently of genome-wide canonical base excision repair of oxidative DNA damage.
- 28 December 2015
- Published by Taylor & Francis in Expert Review of Cardiovascular Therapy
- Vol. 14 (3) , 391-403
A focus on inflammation as a major risk factor for atherosclerotic cardiovascular diseases
Atherosclerosis is a dynamic, pathogenic process in the artery wall, with potential adverse outcome for the host. Acute events such as myocardial infarction and ischemic stroke often result from ru...
- 28 December 2015
- Published by Taylor & Francis in Expert Review of Cardiovascular Therapy
- Vol. 14 (3) , 391-403
A focus on inflammation as a major risk factor for atherosclerotic cardiovascular diseases
Atherosclerosis is a dynamic, pathogenic process in the artery wall, with potential adverse outcome for the host. Acute events such as myocardial infarction and ischemic stroke often result from ru...